Ondansetron and Septic embolus - a phase IV clinical study of FDA data

Summary:

Septic embolus is reported as a side effect among people who take Ondansetron (ondansetron), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Allopurinol, and have Endocarditis.

The phase IV clinical study analyzes which people have Septic embolus when taking Ondansetron. It is created by eHealthMe based on reports of 122,217 people who have side effects when taking Ondansetron from the FDA, and is updated regularly.

What is Ondansetron?

Ondansetron has active ingredients of ondansetron. It is often used in nausea. eHealthMe is studying from 122,739 Ondansetron users. Check the latest studies of Ondansetron.

What is Septic embolus?

Septic embolus (a type of embolism that is infected with bacteria) is found to be associated with 161 drugs and 282 conditions by eHealthMe. Check the latest studies of Septic embolus.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 26, 2026

122,217 people reported to have side effects when taking Ondansetron.
Among them, 13 people (0.01%) have Septic embolus.

Could Ondansetron cause Septic embolus?

Among these 13 people:

How long have people been on Ondansetron when they have Septic embolus? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Septic embolus when taking Ondansetron? *

  • female: 81.82 %
  • male: 18.18 %

What is the age of people who have Septic embolus when taking Ondansetron? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 14.29 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 14.29 %
  • 50-59: 14.29 %
  • 60+: 57.14 %

What are other drugs people take besides Ondansetron? *

  1. Allopurinol: 4 people, 30.77%
  2. Carboplatin: 3 people, 23.08%
  3. Etoposide: 3 people, 23.08%
  4. Cisplatin: 3 people, 23.08%
  5. Dactinomycin: 3 people, 23.08%
  6. Acetaminophen: 2 people, 15.38%
  7. Pantoprazole: 2 people, 15.38%
  8. Morphine: 2 people, 15.38%
  9. Methotrexate: 2 people, 15.38%
  10. Sodium Bicarbonate: 2 people, 15.38%

What are other side effects people have besides Septic embolus? *

  1. Neutropenic Sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection): 4 people, 30.77%
  2. Endocarditis (inflammation in heart muscle): 4 people, 30.77%
  3. Staphylococcal Infection (an infection with staphylococcus bacteria): 3 people, 23.08%
  4. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 3 people, 23.08%
  5. Ototoxicity (damage to the ear): 3 people, 23.08%
  6. Septic Shock (shock due to blood infection): 3 people, 23.08%
  7. Staphylococcal Bacteraemia (a bacterial infection of blood): 2 people, 15.38%
  8. Cerebral Ischaemia (insufficient blood flow to the brain to meet metabolic demand): 2 people, 15.38%
  9. Cerebral Haemorrhage (bleeding within the brain): 2 people, 15.38%
  10. Drug Resistance (reduction in effectiveness of a drug): 2 people, 15.38%

What are the existing conditions these people have? *

  1. Pain: 2 people, 15.38%
  2. Gestational Trophoblastic Tumor: 2 people, 15.38%
  3. Endocarditis (inflammation in heart muscle): 2 people, 15.38%
  4. Weight Loss: 1 person, 7.69%
  5. Urate Nephropathy (disease or abnormality of the kidney): 1 person, 7.69%
  6. Staphylococcal Bacteraemia (a bacterial infection of blood): 1 person, 7.69%
  7. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 7.69%
  8. Metastatic Choriocarcinoma (cancer of embryo covering cells can spread to other part): 1 person, 7.69%
  9. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 7.69%
  10. Endocarditis Staphylococcal (an inflammation of the inner layer of the heart by staphylococcal bacterial infection): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Ondansetron and have Septic embolus?

- Check whether Septic embolus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ondansetron:

Septic embolus treatments and more:

How severe was Septic embolus and when was it recovered:

Expand to all the drugs that have ingredients of ondansetron:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ondansetron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Septic embolus:

Browse all the conditions that are associated with Septic embolus:


How the study uses the data?

The study uses data from the FDA. It is based on ondansetron (the active ingredients of Ondansetron) and Ondansetron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: